Drug – bio-affecting and body treating compositions – Multiple sclerosis
Reexamination Certificate
2007-06-26
2007-06-26
Richter, Johann (Department: 1616)
Drug, bio-affecting and body treating compositions
Multiple sclerosis
C424S703000, C514S708000, C514S709000, C514S711000
Reexamination Certificate
active
10524144
ABSTRACT:
The invention relates to the use of treosulfan and/or derivatives thereof for producing a pharmaceutical composition used in the treatment of multiple sclerosis.
REFERENCES:
patent: 01 32154 (2001-05-01), None
patent: WO 01/32154 (2001-05-01), None
Fridman, Igor Surface area of Human Skin 2001.
H. Openshaw et al., “Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: Report of toxicity and immunological monitoring”, Biology of Blood and Marrow Transplantation, vol. 6, No. 5a, pp. 563-575, XP002263510.
Rieckmann, Immunmodulatorische Therapie der Multiplen Sklerose, 2002: 109-118.
Goodin et al, Neurology 58, Jan. 2002, pp. 169-178.
Specialist information “Novantron®” (Wyeth Pharma GmbH), Jan. 2002.
Weissert et al, J. Clin. Invest., 1998, 102:1265-1273.
Weissert et al, The Journal of Immunology, 1998, 160:681-690.
Weissert et al, The Journal of Immunology, 2001, 166:7588-7599.
Hauser et al, N. Engl. J. Med., 1983, 308:173-180.
Openshaw et al, Biology of Blood and Marrow Transplantation 2000, 6:563-575.
Arnold Ernst V
Medac Gesellschaft fur Klinische Spezialpraparate mbH
Nixon & Vanderhye P.C.
Richter Johann
LandOfFree
Use of treosulfan and derivatives thereof for treating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of treosulfan and derivatives thereof for treating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of treosulfan and derivatives thereof for treating... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3843383